Atlas Trials

A Phase Ib Study of GB491 Plus Letrozole in Patients With Advanced Breast Cancer

Clinical trial NCT05337657 · UNKNOWN

Trial details

NCT number
NCT05337657
Sponsor
Genor Biopharma Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Advanced Breast Cancer
Start date
2021-06-02
Primary completion
2023-12-12
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.